Skip to content
healthcare.dev

DALVANCE

NDC 57970-100, Dalbavancin, injection, powder, for solution, from Allergan, Inc..

Product NDC
57970-100
Status
Listed
Labeler
Allergan, Inc.
Dosage form
INJECTION, POWDER, FOR SOLUTION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA021883
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/57970-100 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • DALBAVANCIN HYDROCHLORIDE500 mg/25mL

Pharmacologic classes

Lipoglycopeptide Antibacterial [EPC]; Lipoglycopeptides [CS]

Package NDCNDC-11Package
57970-100-01579700100011 VIAL in 1 PACKAGE (57970-100-01) / 25 mL in 1 VIAL

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/4b4674d8-4d1e-4728-8465-d42ada33fa5c
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=57970-100

Use it

Look up 57970-100 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/57970-100 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 57970-100. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.